John Yetimoglu
Director, Biohaven Pharmaceuticals.
Companies
- Biohaven PharmaceuticalsBoard member Aug 14, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Biohaven Pharmaceuticals BHVN6,250,000 shares2$70.2M at $11.24Aug 14, 2026
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2